Stephen Thomas Keir1. 1. Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center at Duke, DUMC Box 3624, Durham, NC 27710, USA. keir0001@mc.duke.edu
Abstract
BACKGROUND: Patients with brain tumors report experiencing elevated levels of stress across the disease continuum. Massage therapy is a commonly used complementary therapy and is employed in cancer care to reduce psychological stress and to improve quality of life (QoL). The purpose of this pilot study was to obtain a preliminary assessment of the efficacy of massage therapy on patient reported psychological outcomes and QoL. MATERIALS AND METHODS: The design of the study was a prospective, single-arm intervention. Participants were newly diagnosed primary brain tumor patients who reported experiencing stress and who received a total of eight massages over a period of 4 weeks. Participants completed the Perceived Stress Scale (PSS-10) and the Functional Assessment of Cancer Therapy-Brain to assess their stress level and QoL. RESULTS: As a group, levels of stress dropped significantly between weeks 2 and 3 (M = 12.3, SD = 3.09, P ≤ 0.010). A trend for the reduction in stress continued through week 4 (P ≤ 0.063). At the end of week 4, PSS-10 scores of all participants were below the threshold for being considered stressed. By the end of the intervention, participants reported significant improvements in three test domains, emotional well-being, additional brain tumor concerns, and social/family well-being. CONCLUSION: This study indicates that participation in a massage therapy program is both feasible and acceptable to newly diagnosed brain tumor patients experiencing stress. Furthermore, participants in this study reported improvements in stress and their QoL while receiving massage therapy.
BACKGROUND:Patients with brain tumors report experiencing elevated levels of stress across the disease continuum. Massage therapy is a commonly used complementary therapy and is employed in cancer care to reduce psychological stress and to improve quality of life (QoL). The purpose of this pilot study was to obtain a preliminary assessment of the efficacy of massage therapy on patient reported psychological outcomes and QoL. MATERIALS AND METHODS: The design of the study was a prospective, single-arm intervention. Participants were newly diagnosed primary brain tumorpatients who reported experiencing stress and who received a total of eight massages over a period of 4 weeks. Participants completed the Perceived Stress Scale (PSS-10) and the Functional Assessment of Cancer Therapy-Brain to assess their stress level and QoL. RESULTS: As a group, levels of stress dropped significantly between weeks 2 and 3 (M = 12.3, SD = 3.09, P ≤ 0.010). A trend for the reduction in stress continued through week 4 (P ≤ 0.063). At the end of week 4, PSS-10 scores of all participants were below the threshold for being considered stressed. By the end of the intervention, participants reported significant improvements in three test domains, emotional well-being, additional brain tumor concerns, and social/family well-being. CONCLUSION: This study indicates that participation in a massage therapy program is both feasible and acceptable to newly diagnosed brain tumorpatients experiencing stress. Furthermore, participants in this study reported improvements in stress and their QoL while receiving massage therapy.
Authors: T Field; G Ironson; F Scafidi; T Nawrocki; A Goncalves; I Burman; J Pickens; N Fox; S Schanberg; C Kuhn Journal: Int J Neurosci Date: 1996-09 Impact factor: 2.292
Authors: Stephen T Keir; Roberta D Calhoun-Eagan; Jonas J Swartz; Oussama A Saleh; Henry S Friedman Journal: Psychooncology Date: 2008-06 Impact factor: 3.894
Authors: David K Wellisch; Thomas A Kaleita; Donald Freeman; Timothy Cloughesy; Jeffrey Goldman Journal: Psychooncology Date: 2002 May-Jun Impact factor: 3.894
Authors: T M Field; S M Schanberg; F Scafidi; C R Bauer; N Vega-Lahr; R Garcia; J Nystrom; C M Kuhn Journal: Pediatrics Date: 1986-05 Impact factor: 7.124
Authors: Anthony Byrne; Anna Torrens-Burton; Stephanie Sivell; Fabio Ynoe Moraes; Helen Bulbeck; Mark Bernstein; Annmarie Nelson; Helen Fielding Journal: Cochrane Database Syst Rev Date: 2022-01-06